Abstract
Background: The recent mobile technology advancements, such as the development of applications (apps) for mobile phones and tablets, can assist in the development of low-cost platforms to monitor therapeutic adherence or complications, providing easily accessible information or guidelines in self-care focused on the care recipient.
Objective: The aim of this study was to gather scientific evidence about the efficacy of the use of mobile apps during chemotherapy treatments.
Methods: A systematic review of quantitative studies was performed. All articles published until May 31, 2019 were identified in databases MEDLINE, CINAHL Psychology and Behavioral Sciences Collection, and Cochrane Library.
Results: A total of 10 quantitative studies were included. A set of metrics was identified that essentially analyze issues related to the devices' functionalities. The metrics associated with engagement and related to behavioral dimensions, associated with the use of/adherence to the mobile app, are predominant. The clinical metrics represent 25 of a total of 53 identified metrics. Beneficial and statistically significant results were identified related to fatigue, self-efficacy, and improvements in reports of complications.
Conclusion: Based on the available research, mobile apps are likely to be a useful and acceptable tool to monitor interventions and complications. In addition, mobile apps can help in the self-management of treatment-related complications. Importantly, these apps need to bridge the academic context and clinical practice, by evaluating the impact of the use of mobile apps in patients.
Implications for Practice: The concept of prescribing apps is being addressed to ensure that apps work and have fair privacy and data security policies that address safety requirements.